Preclinical combo tests were performed at Beth Israel using Kevetrin and a Pfizer drug. It says nothing about Pfizer's involvement. Furthermore, thise tests were wildly successful as noted in this PR: http://m.marketwired.com/press-release/cellceutixs-clinical-trial-anti-cancer-agent-kevetrin-meeting-its-goals-approaching-otc-ctix-2049208.htm Again, we will make a gigantic deal on Kevetrin after we perfect the oral formulation. We want to unlock more easy value before partnering.